Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1997-02-04
1998-12-15
Spector, Lorraine
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
5303871, 436 65, G01N 3353, C07K 1618
Patent
active
058495029
ABSTRACT:
Method of determining if a pregnant patient is at risk of premature delivery comprising analyzing the patient's amniotic fluid for the presence of Annexin I and Annexin I breakdown products, the presence of these breakdown products being predictive of a premature delivery.
REFERENCES:
patent: 5201308 (1993-04-01), Newhouse
patent: 5225183 (1993-07-01), Purewal et al.
patent: 5238683 (1993-08-01), Crystal
patent: 5298489 (1994-03-01), Wallner et al.
patent: 5302581 (1994-04-01), Sarin et al.
patent: 5314890 (1994-05-01), Agostini et al.
patent: 5314992 (1994-05-01), Guyre et al.
patent: 5316915 (1994-05-01), Kraus et al.
patent: 5384128 (1995-01-01), Meezen et al.
Myatt et al. J. Cell. Biochem. 50, 363-373, 1992.
Lynch-Salamon et al. Am. J. Obstet. Gynecol. 167, 1657-1663, 1992.
Reutelingsperger et al., FEBS Letters 349 (1994), pp. 120-124 "Differential tissue expression of Annexin VIII in human."
Tsao FHC, et al., Biochim. Biophys. Acta 1213, 91-99 (1994) "Immunocharacterization and developmental regulation of rabbit lung calcium-dependent phospholipid-binding protein."
Strijbos et al., Am. J. Physiol vol. 265 (1993) E289-E297, "Impaired febrile responses of aging mice are mediated by endogenous lipocortin-1 (annexin-1)".
Strijbos et al., Am. J. Physiol 263, (1992) E632-E636, "Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF".
Das SK et al., Mol. Cellul. Biochem, 115, (1992) pp. 79-84, "Identification of calcium-dependent phospholipid-binding proteins (annexins) from guinea pig alveolar type II cells."
Keith et al., FASEB J. vol. 6 No. 4 Feb. 26, 1992, p. A1162, "Localization of phospholipid binding protein in rabbit lung".
Ambrose et al., American Journal of Respirory Cell and Molecular Biology, vol. 6 (1992) pp. 17-21, "Lipocortin I Production by Human Alveolar Macrophages."
Chung et al., Respiratory Medicine 85, 1991, 121-124 "Circulating autoantibodies to recombinant lipocortin-1 in asthma".
Perretti et al., Journal of Immunology, vol. 151, 1991 pp. 4307-4314, "Lipocortin-1 Fragments Inhibit Neutrophil Accumulation and Neutrophil-Dependent Edema in the Mouse".
Tsao FHC et al., "Lung calcium-dependent phospholipid-binding proteins: structure and function" Biochim. Biophys Acta 1081, 1991, 141-150.
Strijbos et al., American Journal of Physiological Society vol. 263 (1990) 11p, "Central and Peripheral Actions of Recombinant Lipocortin-1 and a Fragment of Lipocortin-1 on the Responses to Interleukin-1B".
Smith et al., Environmental Health Perspective vol. 85, 1990, pp. 135-144, "Detection of Lipocortin 1 in Human Lung Lavage Fluid; Lipocortin Degradation As a Possible Proteolytic Mechanism in the Control of Inflammatory Mediators and Inflammation".
Smith, S. F., et al. 151(4), (1995) p. A484, "Comparison of lipocortin 1 in human bronchoalveolar lavage (BAL) cells ex vivo and in vitro."
Drost, E. M., et al. 151(4), (1995) p. A453, "Effect of lipocortin 1 (Lcl) on human polymorphonuclear neutrophil (PMN) deformability."
Tsao, F. H. C., et al. 151(4), (1995) p. A741, "Structure and function of annexin I in human bronchoalveolar lavage fluid."
Lucht et al. (1988) Am. J. Med. Sci. 296. 88-102.
Maridonneau-Parini, I, et al. J. Clin. Invest. 83, (1989) pp. 1936-1940, "Inhbtion of 02 generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages."
Perretti, M. et al. Pharmacol. Res. 30, (1994) pp. 53-59, "Cytokines, glucocorticoids and lipocortins in the control of neutrophil migration."
Cirino, G. et al. Proc. Natl. Acad, Sci. USA. 86, (1989) pp. 3428-3432, "Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test."
Relton, J. K. et al. J. Exp. Med. 174, (1991) pp. 305-310, "Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain."
Perretti, M., et al. Br. J. Pharmacol. 103, (1991) pp. 1327-1332, "A novel anti-inflammatory peptide from human lipocortin 5."
Tsao FHC, Biochimica et Biophysica Acta. 1045 (1990) pp. 29-39, "Purification and characterization of two rabbit lung Ca.sup.2+ -dependent phospholipid-binding proteins".
Ambrose et al., Am. J. Respir. Cell Mol. Biol. vol. 3, 1990, pp. 349-353, "Corticosteroids Increase Lipocortin I in Alveolar Epithelial Cells".
Ambrose et al., J. Appl. Physiol (68) 1990, pp. 1668-1671, "Corticosteroids increase Lipocortin I in BAL fluid from normal individuals and patients with lung disease".
Carey, et al., J. Physiol vol. 259 1990, R266-R269, "Lipocortin 1 fragment modifies pyroenic actions of cytokines in rats".
Sakata et al., The Journal of Immunology vol. 145, No. 1, 1990 387-396 "The Role of Lipocortin I in Macrophage-Mediated Immunosuppresion in Tumor-Bearing Mice".
Davidson J., et al. Br. J. Pharmacol. 102, (1991) pp. 7-9, "Antipyretic actions of human recombinant lipocortin -1."
Basi Nirmal S.
Spector Lorraine
Wisconsin Alumni Research Foundation
LandOfFree
Annexin containing compositions and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Annexin containing compositions and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Annexin containing compositions and methods for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456560